top of page
DSC_5874-edit_edited3@1920.jpg

Focusing on What Matters

The missing piece in effort to achieve
better values and outcomes.

Approximately 50% of patients have medication errors post-discharge.

Drugs can do more harm than good
if not taken properly.

For every 100 prescriptions, only 15 – 20% are taken properly on a regular basis.


72% of post-discharge adverse events are medication-related.

 

60% of all medication error occur during times of care transition.

Medically complex patients have difficulty keeping up
with multiple medications throughout the day.
This requires several visits to the doctors and to the pharmacy.

Regimen changes expose patients to even greater risk
from medication error and poor adherence.

Carepak eliminates preventable costs while maximizing patient's adherence to medication.

Source: 1. IMS Health Date, March 2011. 2. Improving Care Transitions: Optimizing Medication, March 2012. APhA/ASHP.
3. Wittkowsky A. K. Impact of target specific oral anticoagulants on transitions of care and outpatient care models.
J Thromb Thrombolysis. 2013; 35: 304–311.

Healthcare spending increases as the number of chronic conditions increases.

2006 Per Capita Medicare Spending by Chronic Conditions

$2,626

$4,039

$5,972

$7,116

$10,133

1

2

3

4

5

Number of Chronic Conditions

Source: Avalere Health analysis of the 2006 Medicare Standard Analytic Files

High-risk Medicare beneficiaries spend close to 4x more than other beneficiaries per year.

Medicare Spending

High-risk beneficiaries vs. other beneficiaries per year

$6,549

Other Beneficiaries

$23,076

High-risk Beneficiaries

Source: Focusing on High-cost Patients: the Key to Addressing High Costs? J. Michael McWilliams, MD, PhD and Aaron L. Schwartz, PhD †High-risk beneficiaries
were defined as having both a Hierarchical Condition Category score and a count of conditions in the Chronic Condition Data Warehouse in the top quartile of
the distributions of these characteristics.

Increased adherence rate results in significantly lower hospitalization.

Relationship Between Adherence and Hospitalization

15%

12%

10%

Hospitalization Rate

5%

4%

<40%

40–59%

60–79%

80 – 99%

100%

Adherence Rate

Source: D.T. Lau and D.P. Nou, “Oral Antihyperglycemic Medication Nonadherence and Subsequent Hospitalization Among Individuals with Type 2 Diabetes.” Diabetes Care, September, 2004.

2.54-fold Higher Readmission Rate in Low & Intermediate Adherent Group

Patients with low and intermediate adherence have a readmission rate of 20.0% compared to
a readmission rate of 9.3% for patients with high adherence. During a 30-day readmissions measure, patients with low and intermediate medication adherence had an adjusted 2.54-fold higher odds of readmission compared to those in patients with high adherence.

Source: Rosen OZ, Fridman R, Rosen BT, Shane R, Pevnick JM. Medication adherence as a predictor of 30-day hospital readmissions. Patient Prefer Adherence. 2017;11:801-810. https://doi.org/10.2147/PPA.S125672 

Medication adherence is the key to reducing readmission and cost.

Carepak’s Adherence Score
(EQuiPP Score)

March 2019 – October 2019

90.6%

Cholesterol PDC

90.9%

Diabetes PDC

90.9%

RASA PDC

Results include patients who are deceased and
admitted to long-term care facility.

Adherence is measured by Proportion of Days Covered (PDC) which assesses the percentage of patients covered by prescription claims for the same drug or for another drug in the same therapeutic class, within the measurement year. The PDC threshold is the level above which the medication has a reasonable likelihood of achieving the most clinical benefit (80%).

bottom of page